GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
NASDAQ:GDRX - US38246G1085 - Common Stock
4.56 USD
+0.07 (+1.56%)
4.6 USD
+0.04 (+0.88%)
Taking everything into account, GDRX scores 5 out of 10 in our fundamental rating. GDRX was compared to 35 industry peers in the Health Care Technology industry. GDRX has only an average score on both its financial health and profitability. GDRX is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, GDRX could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year GDRX was profitable.
In the past year GDRX had a positive cash flow from operations.
GDRX had negative earnings in 4 of the past 5 years.
In the past 5 years GDRX always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.20%, GDRX belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.35%, GDRX belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
GDRX has a Return On Invested Capital of 5.43%. This is amongst the best in the industry. GDRX outperforms 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.2% | ||
| ROE | 4.35% | ||
| ROIC | 5.43% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GDRX has a better Profit Margin (3.57%) than 88.57% of its industry peers.
GDRX's Profit Margin has declined in the last couple of years.
GDRX's Operating Margin of 10.28% is amongst the best of the industry. GDRX outperforms 85.71% of its industry peers.
In the last couple of years the Operating Margin of GDRX has declined.
Looking at the Gross Margin, with a value of 93.84%, GDRX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.28% | ||
| PM (TTM) | 3.57% | ||
| GM | 93.84% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDRX is destroying value.
The number of shares outstanding for GDRX has been reduced compared to 1 year ago.
GDRX has about the same amout of shares outstanding than it did 5 years ago.
GDRX has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.18, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
GDRX's Altman-Z score of 1.18 is in line compared to the rest of the industry. GDRX outperforms 57.14% of its industry peers.
GDRX has a debt to FCF ratio of 6.21. This is a slightly negative value and a sign of low solvency as GDRX would need 6.21 years to pay back of all of its debts.
The Debt to FCF ratio of GDRX (6.21) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.74 indicates that GDRX is somewhat dependend on debt financing.
GDRX's Debt to Equity ratio of 0.74 is on the low side compared to the rest of the industry. GDRX is outperformed by 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.21 | ||
| Altman-Z | 1.18 |
ROIC/WACC0.5
WACC10.79%
2.3 Liquidity
A Current Ratio of 5.23 indicates that GDRX has no problem at all paying its short term obligations.
GDRX has a better Current ratio (5.23) than 91.43% of its industry peers.
A Quick Ratio of 5.23 indicates that GDRX has no problem at all paying its short term obligations.
GDRX's Quick ratio of 5.23 is amongst the best of the industry. GDRX outperforms 91.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.23 | ||
| Quick Ratio | 5.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.67% over the past year.
The earnings per share for GDRX have been decreasing by -24.47% on average. This is quite bad
Looking at the last year, GDRX shows a small growth in Revenue. The Revenue has grown by 5.61% in the last year.
Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
Revenue 1Y (TTM)5.61%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
3.2 Future
GDRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.30% yearly.
The Revenue is expected to grow by 5.48% on average over the next years.
EPS Next Y19.87%
EPS Next 2Y19.07%
EPS Next 3Y16.92%
EPS Next 5Y24.3%
Revenue Next Year3.3%
Revenue Next 2Y4.32%
Revenue Next 3Y5.19%
Revenue Next 5Y5.48%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
GDRX is valuated correctly with a Price/Earnings ratio of 13.03.
GDRX's Price/Earnings ratio is rather cheap when compared to the industry. GDRX is cheaper than 97.14% of the companies in the same industry.
GDRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.24.
The Price/Forward Earnings ratio is 9.75, which indicates a very decent valuation of GDRX.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaper than 97.14% of the companies in the same industry.
GDRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.03 | ||
| Fwd PE | 9.75 |
4.2 Price Multiples
80.00% of the companies in the same industry are more expensive than GDRX, based on the Enterprise Value to EBITDA ratio.
85.71% of the companies in the same industry are more expensive than GDRX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.59 | ||
| EV/EBITDA | 11.47 |
4.3 Compensation for Growth
GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GDRX may justify a higher PE ratio.
GDRX's earnings are expected to grow with 16.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y19.07%
EPS Next 3Y16.92%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.56
+0.07 (+1.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners59.43%
Inst Owner Change-2.01%
Ins Owners11.7%
Ins Owner Change4.09%
Market Cap1.63B
Analysts75.65
Price Target6.44 (41.23%)
Short Float %7.56%
Short Ratio2.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.88%
Min EPS beat(2)-8.64%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.74%
Min EPS beat(4)-10.15%
Max EPS beat(4)-7.12%
EPS beat(8)4
Avg EPS beat(8)0.12%
EPS beat(12)8
Avg EPS beat(12)16.11%
EPS beat(16)10
Avg EPS beat(16)12.75%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.2%
Revenue beat(12)2
Avg Revenue beat(12)-1.38%
Revenue beat(16)2
Avg Revenue beat(16)-1.48%
PT rev (1m)0%
PT rev (3m)-3.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.03 | ||
| Fwd PE | 9.75 | ||
| P/S | 2.04 | ||
| P/FCF | 20.59 | ||
| P/OCF | 10.84 | ||
| P/B | 2.49 | ||
| P/tB | 48.34 | ||
| EV/EBITDA | 11.47 |
EPS(TTM)0.35
EY7.68%
EPS(NY)0.47
Fwd EY10.26%
FCF(TTM)0.22
FCFY4.86%
OCF(TTM)0.42
OCFY9.23%
SpS2.23
BVpS1.83
TBVpS0.09
PEG (NY)0.66
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.2% | ||
| ROE | 4.35% | ||
| ROCE | 6.88% | ||
| ROIC | 5.43% | ||
| ROICexc | 7.27% | ||
| ROICexgc | 23.96% | ||
| OM | 10.28% | ||
| PM (TTM) | 3.57% | ||
| GM | 93.84% | ||
| FCFM | 9.92% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.95%
ROICexcg growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.21 | ||
| Debt/EBITDA | 3.11 | ||
| Cap/Depr | 95.67% | ||
| Cap/Sales | 8.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.09% | ||
| Profit Quality | 278% | ||
| Current Ratio | 5.23 | ||
| Quick Ratio | 5.23 | ||
| Altman-Z | 1.18 |
F-Score8
WACC10.79%
ROIC/WACC0.5
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
EPS Next Y19.87%
EPS Next 2Y19.07%
EPS Next 3Y16.92%
EPS Next 5Y24.3%
Revenue 1Y (TTM)5.61%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%1.23%
Revenue Next Year3.3%
Revenue Next 2Y4.32%
Revenue Next 3Y5.19%
Revenue Next 5Y5.48%
EBIT growth 1Y368.45%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year37.85%
EBIT Next 3Y17.74%
EBIT Next 5Y12.79%
FCF growth 1Y-13.95%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y0.88%
OCF growth 3Y0.94%
OCF growth 5Y17.16%